Penn Bone Marrow and Stem Cell Transplant Center
Penn Bone Marrow and Stem Cell Transplant Program, approved and funded by the National Cancer Institute, is one of the largest and most experienced transplant programs in the country. Penn Bone Marrow Transplant Program has pioneered many advances in the care of bone marrow transplant patients, including the use of autologous stem cell grafts, transplantation using unrelated and mismatched sibling donors, and developing less toxic non-myeloablative preparatory regiments that improve outcomes and decrease toxicity. Penn transplant team has decades of transplantation experience including expertise in transplantation of patients with myelofibrosis and other high risk myeloproliferative disorders. The transplant care is closely coordinated between our dedicated inpatient transplant unit and the outpatient clinic, with a clinical team of experienced transplant physicians, nurses, nutritionists, physical therapists and social workers who understand the multitude of personal issues faced during transplant.